Return to CBI Antibody Core Home Page
  Return to Drosophila list
    Return to fruit fly ( Drosophila melanogaster ) list


fruit fly ( Drosophila melanogaster )
CG14438


Links to multiple antibodies on this page for CG14438:
CG14438
CG14438


Western result: ++
control
CG14438
A1010a
(fragment)

N.A. kDa (recombinant)
The western blot contains a test lane of ~20ug of a total protein extract from E coli with ~50ng to 500ng of the antigen (recombinant fusion protein containing a His tag). The negative control lane is the same except it contains ~50ng to 100 ng of a recombinant fusion protein of an irrelevant antigen. The blot was probed with a final antisera dilution of 1:1,000. The secondary antibody (Rabbit anti-mouse IgG + IgM, (H+L) horseradish peroxidase conjugated (Pierce)) is used at 1:5,000 dilution. Note, the molecular weight of the band on the western blot does not correspond to the molecular weight of the natural protein because only a fragment of the gene is used.

Antibody Name/Abbreviation: CG14438
CBI Antibody Core Code: A1010a

"Lot" Number: 2 Position: 25 (390-414)
% Identical Homology of Target to Mouse Protein: 0%
Molecular Weight of GST-fusion: N.A. KDa

Target sequence used to make this antibody:
ASNINDPRGRKGINLPETNNNKDND






Antibody Name/Abbreviation: CG14438
CBI Antibody Core Code: A1010b

"Lot" Number: 1 Position: 20 (289-308)
% Identical Homology of Target to Mouse Protein: 0%
Molecular Weight of GST-fusion: 29.2 KDa

Target sequence used to make this antibody:
FSRRSYTTSSQSTCRSSEIS






Sequence Name: CG14438
Full name: CG14438
UniGene Number: N.A.
Accession Number: Q9W3W6
Source organism: fruit fly ( Drosophila melanogaster )
Full length size (aa): 3313
NCBI information page:

Full length sequence:
MEDSEDDVVVVSCDTSMKEKVKAKLVEIRKFVPFIRRVRIDFQDTLSKVQ
GHRLDALVNLLDREDVSMSSLNKIEVIIDKLRTRFNPRIEIDTGEIIDIT
ENTEYDSTASSSSGSSAQPPAQRAKSSDKGGLLNGSSLAGRLNASLNPAS
DATKDHLSTPKQLELERNSKVSCSTSKIKTSSISAKISVFPATSMDLNIP
KTTSAKASDEGQRSPAEPRAALQAIVQDTKTPTIPEPTSPAALKHSSLRG
SRGFLAVMQKALIEEKKQRASEQKTDKETNGVTQLETNFSRRSYTTSSQS
TCRSSEISVRAENPDFKRRSTSLVQHAPLQEASPGQSKKDLPISLSVQGL
PALVSASTASPANTLEEARKKLAALKYGLGTTVPSMPPLASNINDPRGRK
GINLPETNNNKDNDLGIALQSPPPMRTPSPIPPPPRMKAGTWASFSNVPQ
ESAFTGQHAVQRNSVPPGDSRAFGDALAHEPRSFYGTDSREPRDPRIWKS
KTSQQQQHQQAPQAQIPPYSSDPRRSISTYSGFEESANRGQTNSKNNNNH
NQNQNVTANGSAYIANWSGNPYGNGPNPRPPFPSNQNGNEYAGGFNGSHS
FRGGFRGGHNKRGFGRHNDVPRTYGEHRKAKARAEAEAKAKAEAEAKAKA
AAEAKAKAAAEVRQLETEVSREMEAQEKNKQQKEKPEESEAEKSTIAVTQ
VPELDTSYRNVNLGVLNKKLDFRIPKKTLPPATTITSTSPVNGNGENPSC
PSNSPTSKSCDANQDKDTYKNKDRYLNKAKAKDKVDKGNEVSENNLDKSE
KLEKSQDKKANDKENKSDKKEKKRLNREPEKKSKVENPLEIVDSNSVVSE
ESSENTDNVENEPPLSETNASPVPELATSTQDSQQDQSVSEELDILAKNR
RMSGTRIKTPISSTGNPALKRRADDDVEDKLENPTKKNCAKWEAKPDKEK
SEDDTIDKIKSMKVTKFADVEMKVTEESQSAEEEEITEQKESTEEEEGTE
HKKSTEEKDKPPKISKIKIVLTPIAHTTQVVRPNDGFKNNQEKILDNMAT
DEHDDEEVPGPPAQFLRRIMQRRNSLAPTYMKPMVDKDKIASSSFTYEDL
PEQKRGNQNARNLAIIFEKTSDNCSVSTQNIINGKRRTRGCETSFNETQL
SRNIFGMGQINRSRPKATEGKATRAKISVPAKDSTRADDDPIPTPNLKRK
RQAIHKETEDDVEMKPKKARLEAQEINGVSVTPDEQQVENNVEVTQKEVE
AISSEPLLSSEVEPTRKPRTKPRKNELDKLNDDIAQMYYGEEVMRATSRR
ACTRRSRTSSHTRTSSQHSRTSSVSRTDSISTVSDISSIIVRNTARRGRG
IRSSENGINRATFNASLNAKKPKLCRVRIKRCAALMEMIKDQEKEEQEKK
EQKNKEPKKKKVGVQKKPLKSKPKRENSVILNTNPEWHSISKAVIKCVVC
SKWVRRSPLSHYMMCHKEHYAARLPPDVLKELRAGRGNRPDYWVSQRGGY
TLHFTCPFCQKPLLLCQKGMIEHLIGHMGESRFYCSNCNMPQNRLSRLLD
HTASCGPGAKPLSSKTVCLPMSVHVCHICQFMQYSKENMDRHLTVQHGLT
KEELESVEREELMLCDTTDVPYADSNKDGSAVGPEIQKNKPKSKASAALS
NTTKKNKQQKKTNNSRFMKMVKKSVSLLKREREEQDDQNMTQANEGSEVP
EIPPPPPEIEPLFVVNECLMTSEMDTDMEEVLEQPVQHMSLMVDEKPVTL
LSGATEQLEPSVPDPEPVVPSAQDDGKDVNEDEDVDVEAVVDSLQSHTDQ
TATSMLAEVSLAELAGDVLDGIGSDASDYEMDDNSEQVDTTNKNGYGDDD
DDALTDDWVDLETAKRNSKSAKSIFRVFNRFCSRLNKLPRSSRAVPSNGS
ENSDGSDNNDDDGDNPDPSELMPTMQPLEPEPEMGDSSTSTGAKSLSERV
ENVGFQKPSSDEDQNRVAASYYCVQPGCTFLFSNELEGLENHFALEHPLV
RWSGKCGMCRQKITATETNLRISEELRHMRDVHMKDISTLPPPQSSAVES
PAVIESCLNQREPVPESEPDPVPELPKLRVRRFTGDRLVVDSQAEKSQPV
AIVVSDDDNPRNGMLRDLLAADPRPPNQQLDLQAAGLGEFLCAKPDSPST
EPVKQTPVIVGYSSGLGLKIGQVLSRTQISANSRLSPVVNDPLPEKSSAP
AAVEENRNRFRCMATNCNFVAHKLMFMREHMKFHSYSFSSTGHLNCAYCS
HVAVDVDDYLRHGVIIHDLAPRSELESSTGPPSVTQKIRDMLSQRENGRV
PPPTPQVTLSDVVLGLLECTGYSEDKLYACPQKGCIVRLTDEQLVNHLRY
HIRSTHQGSELVKCKFCTKAMHPPALRTHLQQYHARHSIFCGICLATSVN
QRIMMYHMSTVHSKAYGRPNARLAFVSLPVKIDASKKNVESEFYVAVVEQ
PFGNLQMQDFQRKLFDEMDRRRSGTKTYFRSSEVHILPTQPTFQRPLYCT
ECPFSTTSRVNMQMHLYEHKDETIREASKLADLIVPATSSVLTVSASTLV
APPRPGKDSEKPSTSGQSGDAATEQLNPDVPGTHKPIKPPLRYVPPDQRY
RCGFLRCSVLCFSESAVRKHMQANHKYSEVVRCPHCKNCQGQFGVDKYFD
HLAMHKRHIFQCGACSRHNSRRVIERHIQERHNIQDVDMIVHRHNDSNKT
TEARWLKAPKLARHSLMEYTCNLCLKYFPTTVQIMAHAASVHKRNYQYHC
PYCEFGGNLATALIEHILREHPEREVQPVQIYQRIVCKNKQTLGFYCTTC
HEVASSFQKIAMHCDKEHKSRNPVQCPHCIFGHLAERQVVLHIQEKHPHE
RGLAMVQFERVLNDIPNSISWEIGRPIEVEPEKEIPNNGESAFLPLSQRQ
VVTEVVDLLDSDDEADEYGEQDDAKIVEFACTHCDGTNTNLPDLRSQHWA
REHPDQPFYFRVQPMLLCSECKRFRGNAKALREHLRATHSIRSIVAADIR
RPMECAYCDYRYKNRHDLAKHISEIGHLPNDLKHVTDDEIDALMLLSASG
SGGAVNEYYQCGLCSVVMPTKETIVQHGQVEHCKPDERFCFRQLVSPVIY
HCSFCMFNSTDELTTLRHMVDHYSRFLVCHFCTRSQPGGFDEYIQHCYTY
HRDDIKSFRDVHTFSDLKRYLSQVHYQFQNGLIITKSSLRYTRYKSDKCM
LELDAELMAKAQRPPIPRLHIRLKSTGVQMQSPEGADVEKPVSLLRITKR
RKTLNPGELLRSFREENEVQPQPPASSTSSGTAPSPAAGSVFNLFKRRNS
LVVRPATSNLDQH





Questions? Click here for answers.


© Monday, February 16, 2009 by the CBI Antibody Core and the Center for Biomedical Inventions, University of Texas Southwestern Medical School.